BrightSpring Health Services, Inc. (NASDAQ:BTSG) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven ratings firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $24.90.

BTSG has been the subject of a number of recent research reports. TD Cowen initiated coverage on shares of BrightSpring Health Services in a research note on Monday, June 23rd. They issued a "buy" rating and a $37.00 price objective for the company. Mizuho set a $26.00 price objective on shares of BrightSpring Health Services in a research note on Monday, May 5th. Wells Fargo & Company boosted their price objective on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 13th. Wall Street Zen raised shares of BrightSpring Health Services from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Finally, Morgan Stanley upped their price target on BrightSpring Health Services from $20.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th.

BrightSpring Health Services Trading Down 0.5%

Shares of NASDAQ BTSG traded down $0.12 during trading hours on Friday, reaching $22.00. The stock had a trading volume of 1,588,310 shares, compared to its average volume of 1,648,887. The company has a current ratio of 1.73, a quick ratio of 1.37 and a debt-to-equity ratio of 1.48. The firm has a market cap of $3.87 billion, a price-to-earnings ratio of 78.57 and a beta of 2.30. The business's fifty day moving average price is $22.52 and its two-hundred day moving average price is $20.10. BrightSpring Health Services has a 52-week low of $10.15 and a 52-week high of $25.57.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.10. The firm had revenue of $2.88 billion during the quarter, compared to analyst estimates of $2.74 billion. BrightSpring Health Services had a return on equity of 7.76% and a net margin of 0.49%. BrightSpring Health Services's quarterly revenue was up 25.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.12 earnings per share. Analysts expect that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.

Insider Buying and Selling at BrightSpring Health Services

In related news, major shareholder Phoenix Aggregator L.P. Kkr sold 13,288,101 shares of the company's stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $21.15, for a total value of $281,043,336.15. Following the transaction, the insider directly owned 79,671,883 shares of the company's stock, valued at $1,685,060,325.45. This represents a 14.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jon B. Rousseau sold 531,840 shares of the company's stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $21.75, for a total value of $11,567,520.00. Following the completion of the transaction, the insider directly owned 1,184,133 shares in the company, valued at approximately $25,754,892.75. The trade was a 30.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,919,941 shares of company stock worth $337,025,856. 3.40% of the stock is owned by insiders.

Institutional Trading of BrightSpring Health Services

A number of hedge funds have recently modified their holdings of the stock. FMR LLC boosted its stake in shares of BrightSpring Health Services by 21.6% in the fourth quarter. FMR LLC now owns 22,102,490 shares of the company's stock worth $376,405,000 after buying an additional 3,933,303 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of BrightSpring Health Services by 24.6% in the first quarter. Vanguard Group Inc. now owns 6,633,744 shares of the company's stock worth $120,004,000 after buying an additional 1,308,651 shares during the last quarter. Invesco Ltd. boosted its stake in shares of BrightSpring Health Services by 41.0% in the first quarter. Invesco Ltd. now owns 6,172,597 shares of the company's stock worth $111,662,000 after buying an additional 1,794,035 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in shares of BrightSpring Health Services by 264.7% in the first quarter. T. Rowe Price Investment Management Inc. now owns 5,772,772 shares of the company's stock worth $104,430,000 after buying an additional 4,189,805 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of BrightSpring Health Services by 13.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,698,629 shares of the company's stock worth $45,959,000 after buying an additional 328,977 shares during the last quarter.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.